F
Fabien Zoulim
Researcher at French Institute of Health and Medical Research
Publications - 716
Citations - 40988
Fabien Zoulim is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Hepatitis B virus & Hepatitis B. The author has an hindex of 96, co-authored 641 publications receiving 35807 citations. Previous affiliations of Fabien Zoulim include Hotel Dieu Hospital & University of Orléans.
Papers
More filters
Journal ArticleDOI
Synthesis of 5-Haloethynyl- and 5-(1,2-Dihalo)vinyluracil Nucleosides: Antiviral Activity and Cellular Toxicity.
Vanessa Escuret,Vincent Aucagne,Nicolas Joubert,David Durantel,Kimberly L. Rapp,Raymond F. Schinazi,Fabien Zoulim,Luigi A. Agrofoglio +7 more
TL;DR: In this article, the authors reported the synthesis of 5-haloethynyl and 5-(1,2-dihalo)vinyluracil nucleosides in the 2′-deoxy, 3'deoxy- and ribosyl series, and discussed their in vitro anti-HIV and anti-HCV activities and cellular toxicitites.
Journal ArticleDOI
Sequence characterization of extracellular HBV RNA in patient plasma
Silvia Chang,Charlotte Hedskog,Bandita Parhy,Ross Martin,Hongmei Mo,Evguenia Miorova,Fabien Zoulim +6 more
TL;DR:
Journal ArticleDOI
Evaluation of the hepatitis B virus liver reservoir with fine needle aspirates
Barbara Testoni,Armando Andres Roca Suarez,A. Battisti,Marie-Laure Plissonnier,Marintha L. Heil,T. Fontanges,Francois Villeret,Yasmina Chouik,Massimo Levrero,Upkar S. Gill,Patrick T F Kennedy,Fabien Zoulim +11 more
Journal ArticleDOI
The performance of the cobas® HBV RNA assay for use on the cobas® 5800/6800/8800 Systems (RUO) against genomic variants and transcript heterogeneity
Thomas Meister,V. Innocent,Debra Liggett,Alan Blair,Zih-Hua Chen,Abdellali Kelil,Sneha Nishtala,Caroline Scholtes,Barbara Testoni,Marie-Laure Plissonnier,Massimo Levrero,Fabien Zoulim,Marintha L. Heil,Aaron T. Hamilton +13 more
Journal ArticleDOI
Heparanase-1: From Cancer Biology to a Future Antiviral Target
TL;DR: A review of the use of heparanase inhibitors as antivirals can be found in this article , where the authors address the perspectives of using heparanease inhibitors not only for cancer treatment, but also as antivirus drugs.